Sierra Rutile and Iluka get merger go-ahead from German Authority. The German Antitrust Authority has given Sierra Rutile and Iluka Investments clearance to merge – a key condition for the merger to go ahead.
The German Antitrust Authority has given AIM-listed Sierra Rutile and Australian mineral sands miner Iluka Investments clearance to merge – the second of two key conditions to the merger which had to be satisfied for the merger to go ahead.
The boards of Sierra Rutile and Iluka Investments said the merger is now expected to become effective and closing is expected to take place on 29 November this year.
The first condition to the merger was met when Sierra Rutile’s shareholders voted in favour of the resolutions required to approve the merger.
At the closing of the merger, Iluka will provide shareholders with additional information related to the merger and integration priorities.
The merger between Sierra Rutile and Iluka Investments was first announced at the end of October.
As part of the acquisition, Sierra Rutile shareholders would receive 36 pence cash for each Sierra Rutile share.
Iluka Resources also agreed to also assume Sierra Rutile’s debt of approximately US$60 million.
Full Content: Mining Review Africa
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Sex Toy Retailer Says Google Breaches EU Digital Market Rules
May 20, 2025 by
CPI
Latham & Watkins Expands Brussels Antitrust Team
May 20, 2025 by
CPI
Brazil’s Antitrust Watchdog Expected to Approve Pet Retail Merger Without Conditions
May 20, 2025 by
CPI
EU and UK Finalize Deal to Strengthen Antitrust Cooperation
May 20, 2025 by
CPI
Clemens Food Group Reaches $13.5 Million Settlement in Pork Price-Fixing Suit
May 20, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas